| 1 |
35234063 | Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway. | 2022 Jan-Dec |
1 |
| 2 |
35241510 | Combination Treatment of Sorafenib and Bufalin Induces Apoptosis in NCI-H292 Human Lung Cancer Cells In Vitro. | 2022 Mar-Apr |
1 |
| 3 |
35245519 | Antitumor effects of rhamnazinon sorafenib-treated human hepatocellular carcinoma cell lines via modulation of VEGF signaling and PI3K/NF-κB p38/caspase-3 axes cross talk. | 2022 May 15 |
3 |
| 4 |
33825398 | Herbal formula of Bushen Jianpi combined with sorafenib inhibits hepatocellular carcinoma growth by promoting cell apoptosis and blocking the cell cycle. | 2021 Apr |
1 |
| 5 |
30522045 | Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer. | 2019 Feb |
1 |
| 6 |
31387809 | Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenib. | 2019 Oct |
1 |
| 7 |
31389193 | Cell Membrane-Coated Magnetic Nanocubes with a Homotypic Targeting Ability Increase Intracellular Temperature due to ROS Scavenging and Act as a Versatile Theranostic System for Glioblastoma Multiforme. | 2019 Sep |
1 |
| 8 |
29484394 | Anti‑cancer effects of a novel Pan‑RAF inhibitor in a hepatocellular carcinoma cell line. | 2018 Apr |
1 |
| 9 |
30030148 | Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer. | 2018 Nov |
1 |
| 10 |
30132846 | Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells. | 2018 Jan |
1 |
| 11 |
30443188 | The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction. | 2018 |
1 |
| 12 |
27807662 | C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells. | 2017 Feb |
1 |
| 13 |
28096271 | In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis. | 2017 Jul 15 |
2 |
| 14 |
28110575 | Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth. | 2017 May |
1 |
| 15 |
28142087 | Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer. | 2017 Mar |
1 |
| 16 |
28178378 | Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma. | 2017 Apr |
2 |
| 17 |
29072691 | Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib. | 2017 Oct 26 |
1 |
| 18 |
26662956 | Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway. | 2016 May |
2 |
| 19 |
27544320 | Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells. | 2016 Oct 15 |
1 |
| 20 |
27863838 | Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage. | 2016 Dec |
1 |
| 21 |
29431086 | Antitumoral Activity of Sorafenib in Hepatocellular Carcinoma: Effects on Cell Survival and Death Pathways, Cell Metabolism Reprogramming, and Nitrosative and Oxidative Stress. | 2016 |
2 |
| 22 |
25683251 | Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib. | 2015 May |
1 |
| 23 |
25687050 | [Mechanisms of sorafenib induced NB4 cell apoptosis]. | 2015 Feb |
2 |
| 24 |
26057634 | Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients. | 2015 Aug 28 |
1 |
| 25 |
26233703 | Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells. | 2015 Dec |
1 |
| 26 |
24520095 | Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo. | 2014 Mar 1 |
1 |
| 27 |
25136776 | Sorafenib regulating ERK signals pathway in gastric cancer cell. | 2014 Sep |
1 |
| 28 |
25338583 | [Effects of sorafenib on proliferation and apoptosis of human multiple myeloma cell RPMI 8226]. | 2014 Oct |
2 |
| 29 |
22006587 | Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma. | 2013 Jan |
1 |
| 30 |
23243060 | Induction of endoplasmic reticulum stress by sorafenib and activation of NF-κB by lestaurtinib as a novel resistance mechanism in Hodgkin lymphoma cell lines. | 2013 Feb |
1 |
| 31 |
23497499 | Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II. | 2013 Mar 6 |
1 |
| 32 |
23732299 | Anti-proliferative actions of N'-desmethylsorafenib in human breast cancer cells. | 2013 Aug 1 |
1 |
| 33 |
22176637 | Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1 nu mice. | 2012 Apr |
1 |
| 34 |
20197401 | Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. | 2010 Mar |
1 |
| 35 |
20473320 | The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cells. | 2010 Jul |
1 |
| 36 |
20950443 | The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells. | 2010 Oct 15 |
1 |
| 37 |
22993610 | Sorafenib suppresses the cell cycle and induces the apoptosis of hepatocellular carcinoma cell lines in serum-free media. | 2010 Sep |
1 |
| 38 |
19366808 | Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway. | 2009 May 1 |
1 |
| 39 |
17909059 | The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. | 2007 Oct 1 |
1 |
| 40 |
16985072 | Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. | 2006 Sep |
1 |